---
title: "Melanoma Clinical Trials in California"
description: "Find 695 clinical trials for melanoma near California. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/melanoma/california"
---

# Melanoma Clinical Trials in California

Find 695 clinical trials for melanoma near California. Connect with research centers in your area.

- [All Melanoma trials nationwide](https://www.clareohealth.com/clinical-trials/condition/melanoma)
- [All trials in California](https://www.clareohealth.com/clinical-trials/location/california)

Showing 1-20 of 695 trials

### [Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx](https://www.clareohealth.com/clinical-trials/NCT05257486)

Status: COMPLETED · NCT05257486 · Campbell, California and 1 other · Sponsor: Xoft, Inc.

The purpose of this retrospective-prospective study is to evaluate lesions after treatment for BCC or SCC NMSC in order to gain a better understanding of the durability of the trea…

### [Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma](https://www.clareohealth.com/clinical-trials/NCT03743298)

Status: UNKNOWN · Phase: PHASE1 · NCT03743298 · Irvine, California and 1 other · Sponsor: Aivita Biomedical, Inc.

This is an open label, single-arm, phase IB treatment study to determine the safety of administering anti-PD1 monoclonal antibodies with AV-MEL-1 and to get some suggestion of effi…

### [Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma](https://www.clareohealth.com/clinical-trials/NCT01397708)

Status: COMPLETED · Phase: PHASE1/PHASE2 · NCT01397708 · Los Angeles, California and 8 others · Sponsor: Alaunos Therapeutics

This research study involves two investigational drugs, an Activator Ligand (INXN-1001) in combination with an Adenovirus Vector Engineered to Express hIL-12 (INXN-2001).

### [Safety Study of AMG 228 to Treat Solid Tumors](https://www.clareohealth.com/clinical-trials/NCT02437916)

Status: TERMINATED · Phase: PHASE1 · NCT02437916 · La Jolla, California and 6 others · Sponsor: Amgen

The purpose of this study is to evaluate the safety, pharmacokinetics, anti-tumor activity, and identify a tolerable dose of AMG 228 in subjects with advanced solid tumors.

### [Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors](https://www.clareohealth.com/clinical-trials/NCT04774952)

Status: COMPLETED · Phase: PHASE1 · NCT04774952 · Irvine, California and 7 others · Sponsor: Revolution Medicines, Inc.

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-5552 monotherapy in adult part…

### [PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)](https://www.clareohealth.com/clinical-trials/NCT02702492)

Status: TERMINATED · Phase: PHASE1 · NCT02702492 · Los Angeles, California and 7 others · Sponsor: Karyopharm Therapeutics Inc

This study will evaluate the safety, tolerability, and efficacy of oral KPT-9274 for the treatment of patients with advanced solid malignancies or non-Hodgkin's lymphoma (NHL).

### [A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases](https://www.clareohealth.com/clinical-trials/NCT01378975)

Status: COMPLETED · Phase: PHASE2 · NCT01378975 · Los Angeles, California and 32 others · Sponsor: Hoffmann-La Roche

This open-label, single-arm, multicenter study will evaluate the efficacy and safety in participants with metastatic melanoma who developed brain metastases.

### [A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma](https://www.clareohealth.com/clinical-trials/NCT02110355)

Status: COMPLETED · Phase: PHASE1 · NCT02110355 · Los Angeles, California and 6 others · Sponsor: Kartos Therapeutics, Inc.

Phase 1b/2a, open-label, sequential dose escalation and expansion study of AMG 232 in combination with trametinib and dabrafenib in subjects with metastatic melanoma followed by a…

### [Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration](https://www.clareohealth.com/clinical-trials/NCT02339987)

Status: TERMINATED · NCT02339987 · Santa Monica, California · Sponsor: Saint John's Cancer Institute

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

### [Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma](https://www.clareohealth.com/clinical-trials/NCT03070392)

Status: COMPLETED · Phase: PHASE2 · NCT03070392 · Los Angeles, California and 56 others · Sponsor: Immunocore Ltd

To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investigator's Choice of dacarbazine, i…

### [Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma](https://www.clareohealth.com/clinical-trials/NCT02965716)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT02965716 · Mobile, Alabama and 19 others · Sponsor: National Cancer Institute (NCI)

This phase II trial studies how well talimogene laherparepvec and pembrolizumab work in treating patients with stage III-IV melanoma.

### [A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors](https://www.clareohealth.com/clinical-trials/NCT05973487)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · NCT05973487 · Scottsdale, Arizona and 20 others · Sponsor: TScan Therapeutics, Inc.

TScan Therapeutics is developing cellular therapies across multiple solid tumors in which autologous participant-derived engeneered T cells are engineered to express a T cell recep…

### [A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies](https://www.clareohealth.com/clinical-trials/NCT04244552)

Status: TERMINATED · Phase: PHASE1 · NCT04244552 · Phoenix, Arizona and 18 others · Sponsor: Atreca, Inc.

ATRC-101-A01 is a Phase 1b, open-label dose escalation and expansion trial of ATRC-101, an engineered fully human immunoglobulin G, subclass 1 (IgG1) antibody derived from a natura…

### [Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy](https://www.clareohealth.com/clinical-trials/NCT02432963)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · NCT02432963 · Duarte, California · Sponsor: City of Hope Medical Center

This phase I trial studies the side effects of vaccine therapy and pembrolizumab in treating patients with solid tumors that have spread to other places in the body and usually can…

### [Biological Therapy in Treating Patients With Metastatic Cancer](https://www.clareohealth.com/clinical-trials/NCT00002733)

Status: COMPLETED · Phase: PHASE2 · NCT00002733 · Newport Beach, California · Sponsor: Hoag Memorial Hospital Presbyterian

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing.

### [Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients](https://www.clareohealth.com/clinical-trials/NCT03567889)

Status: RECRUITING · Phase: PHASE3 · NCT03567889 · Phoenix, Arizona and 36 others · Sponsor: Philogen S.p.A.

The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-fr…

### [GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2](https://www.clareohealth.com/clinical-trials/NCT05130255)

Status: TERMINATED · Phase: PHASE1 · NCT05130255 · Scottsdale, Arizona and 7 others · Sponsor: Y-mAbs Therapeutics

Patients with Small Cell Lung Cancer, High Risk Neuroblastoma, Sarcoma and Malignant Melanoma will be treated with GD2-SADA:177Lu-DOTA complex(The IMP is a two-step radioimmunother…

### [Study of Cabozantinib (XL184) in Adults With Advanced Malignancies](https://www.clareohealth.com/clinical-trials/NCT00940225)

Status: COMPLETED · Phase: PHASE2 · NCT00940225 · Scottsdale, Arizona and 46 others · Sponsor: Exelixis

This is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.

### [Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery](https://www.clareohealth.com/clinical-trials/NCT00470470)

Status: COMPLETED · Phase: PHASE2 · NCT00470470 · Los Angeles, California and 7 others · Sponsor: National Cancer Institute (NCI)

This phase II trial is studying how well imatinib mesylate works in treating patients with stage III or stage IV melanoma that cannot be removed by surgery.

### [Ph I Ipilimumab Vemurafenib Combo in Patients With v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)](https://www.clareohealth.com/clinical-trials/NCT01400451)

Status: TERMINATED · Phase: PHASE1 · NCT01400451 · Los Angeles, California and 3 others · Sponsor: Bristol-Myers Squibb

Treatment of subjects who have metastatic melanoma that expresses an activated mutant form of the BRAF oncogene (V600E) with a combination of the specific BRAF inhibitor, Vemurafen…

## Melanoma Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/melanoma/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/melanoma/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/melanoma/chicago)
- [Houston](https://www.clareohealth.com/clinical-trials/condition/melanoma/houston)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/melanoma/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/melanoma/philadelphia)

## Other Conditions in California

- [Breast Cancer](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/california)
- [Lung Cancer](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/california)
- [Prostate Cancer](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/california)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/california)
- [Leukemia](https://www.clareohealth.com/clinical-trials/condition/leukemia/california)
- [Lymphoma](https://www.clareohealth.com/clinical-trials/condition/lymphoma/california)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/melanoma/california.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
